In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
Nabi Biopharmaceuticals Acquires Full Rights to Aloprimâ„¢
Akzo Nobel's Diosynth Biotechnology and Human Genome Sciences sign antibody manufacturing agreement
Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.
Nabi Biopharmaceuticals signs international distribution agreement for Nabi-HB(R)
Pharming And Diosynth Biotechnology Sign Manufacturing Agreement For Rec Human C1 Inhibitor
Akzo Nobel unit signs deal with Pfizer
Diosynth Biotechnology Announces Agreement with Pfizer